Hypofractionated stereotactic radiotherapy for large or involving critical organs cerebral arteriovenous malformations

Blamek, Sławomir; Larysz, Dawid; Miszczyk, Leszek; Idasiak, Adam; Rudnik, Adam; Tarnawski, Rafał
January 2013
Radiology & Oncology;2013, Vol. 47 Issue 1, p50
Academic Journal
Background. The treatment of large arteriovenous malformations (AVMs) or AVMs involving eloquent regions of the brain remains a challenge. For inoperable lesions, observation, volume-staged radiosurgery or hypofractionated stereotactic radiotherapy (HFSRT) are proposed. The aim of our study was to assess the safety and efficiency of HFSRT for large AVMs located in eloquent areas of the brain. Materials and methods. An analysis of records of 49 patients irradiated for cerebral AVMs with a mean dose of 19.9 Gy (12-28 Gy) delivered in 2-4 fractions with planned gap (at least one week) between fractions. Actuarial obliteration rates and annual bleeding hazard were calculated using Kaplan-Meier survival analysis and life tables. Results. Annual bleeding hazard rates were 4.5% and 1.6% after one and two years of the follow-up, respectively. Actuarial total obliteration rates were 7%, 11%, and 21% and total response rate (total and partial obliterations) 22%, 41%, and 55% after one, two and three years of the follow-up, respectively. There was a trend towards larger total obliteration rate in patients irradiated with fraction dose ≥ 8 Gy and total dose > 21 Gy for lesions of volume ≤ 8.18 cm3 which was not observed in case of partial obliterations. Conclusions. HFSRT results with relatively low obliteration rate but is not associated with a significant risk of permanent neurological deficits if both total and fraction doses are adjusted to size and location of the lesion. Predictive factors for total and partial obliterations can be different; this observation, however, is not firmly supported and requires further studies.


Related Articles

  • Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery. Yaeh, Andrew; Nanda, Tavish; Jani, Ashish; Rozenblat, Tzlil; Qureshi, Yasir; Saad, Shumaila; Lesser, Jeraldine; Lassman, Andrew; Isaacson, Steven; Sisti, Michael; Bruce, Jeffrey; McKhann, Guy; Wang, Tony // Journal of Neuro-Oncology;Sep2015, Vol. 124 Issue 3, p507 

    Renal cell carcinoma, sarcoma, and melanoma are considered to be 'radioresistant' tumor histologies. Brain metastases (BM) from these tumors are considered unlikely to be controlled using the relatively low doses used in whole brain radiotherapy (WBRT). Our objective was to analyze the efficacy...

  • Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy. Yang, Lin; Hong, Shaodong; Wang, Yan; Chen, Haiyang; Liang, Shaobo; Peng, Peijian; Chen, Yong // Scientific Reports;10/30/2015, p15638 

    The distant metastasis free survival (DMFS) and overall survival (OS) differ significantly among individuals even within the same clinical stages. The purpose of this retrospective study was to build nomograms incorporating plasma EBV DNA for predicting DMFS and OS of nasopharyngeal carcinoma...

  • The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities. Que, Jenny Y.; Li-Ching Lin; Kuei-Li Lin; Chia-Hui Lin; Yu-Wei Lin; Ching-Chieh Yang // Radiation Oncology;2014, Vol. 9 Issue 1, p1 

    Background and aim To evaluate the safety and efficacy of Cyberknife stereotactic body radiation therapy (SBRT) and its effect on survival in patients with unresectable huge hepatocellular carcinoma (HCC) unsuitable of other standard treatment option. Methods Between 2009 and 2011, 22 patients...

  • Stereotactic Radiotherapy for Non-small Cell Lung Cancer with Small Lesions Applying A Flattening Filter Free Clinac. Jianhao GENG; Anhui SHI; Rong YU; Hao WU; Guangying ZHU // Chinese Journal of Lung Cancer;5/20/2015, Vol. 18 Issue 5, p301 

    Background and objective With the rapid development of technology, stereotactic radiotherapy has been widely used. In a cohort of medically operable non-small cell lung cancer patients receiving stereotactic body radiation therapy (SBRT) survival rates "potentially equivalent to those of...

  • Effects of adjuvant chemotherapy and radiation on overall survival in children with choroid plexus carcinoma. Sun, Matthew; Ivan, Michael; Oh, Michael; Delance, Arthur; Clark, Aaron; Safaee, Michael; Oh, Taemin; Kaur, Gurvinder; Molinaro, Annette; Gupta, Nalin; Parsa, Andrew // Journal of Neuro-Oncology;Nov2014, Vol. 120 Issue 2, p353 

    Choroid plexus carcinoma (CPCs) is a rare, malignant, primary brain tumor with a poor prognosis. Currently, there is no consensus on the use of adjuvant therapy, and few large-scale studies focus exclusively on the pediatric population. We performed a comprehensive systematic review of pediatric...

  • Survival Analysis: Part 15 of a Series on Evaluation of Scientific Publications. Zwiener, Isabella; Blettner, Maria; Hommel, Gerhard // Deutsches Aerzteblatt International;3/11/2011, Vol. 108 Issue 10, p163 

    Background: Survival times are often used to compare treatments. Survival data are a special type of data, and therefore have to be analyzed with special methods. Methods: We illustrate special techniques for analyzing survival times by applying them to a publication on the treatment of patients...

  • Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread. Liao, Chun-Ta; Fan, Kang-Hsing; Lin, Chien-Yu; Wang, Hung-Ming; Huang, Shiang-Fu; Chen, I-How; Kang, Chung-Jan; Ng, Shu-Hang; Hsueh, Chuen; Lee, Li-Yu; Lin, Chih-Hung; Yen, Tzu-Chen // European Journal of Nuclear Medicine & Molecular Imaging;Jun2012, Vol. 39 Issue 6, p944 

    Purpose: Extracapsular spread (ECS) to the cervical lymph nodes is a major adverse prognostic factor in oral cavity squamous cell carcinoma (OSCC). We prospectively examined the value of FDG PET immediately before postoperative radiotherapy/concurrent chemoradiotherapy (pre-RT/CCRT PET) to...

  • Triple-Negative Breast Cancer: Clinical Characteristics, Prognostic Features, and Long-Term Outcome: a Comparative Study. Rahmani, Leila; Shahriari Ahmadi, Ali; Mirabbasi, Ali; Zarouk Ahimahalle, Tahere // International Journal of Hematology-Oncology & Stem Cell Researc;Jan2012, Vol. 6 Issue 1, p24 

    Introduction: Because of the reported poor prognosis and absence of effective and specific therapeutic approaches, triple-negative breast cancer (TNBC) tumors have remained as an important area of investigations for clinicians and researchers. The aim of this study was to determine the clinical,...

  • Expression of microRNA-497 and its prognostic significance in human breast cancer. Shaohua Wang; Hanjun Li; Jingjie Wang; Dan Wang // Diagnostic Pathology;2013, Vol. 8 Issue 1, p1 

    Objective Dysregulation of microRNAs (miRNAs) plays critical roles in tumor progression. The aim of this study was to investigate the clinicopathologic and prognostic significance of miR-497 expression in human breast cancer (BC). Methods Taqman qRT-PCR assay was performed to detect the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics